BioCentury | Jun 11, 2015
Distillery Therapeutics

Therapeutics: RNA 3'-terminal phosphate cyclase (RTCA)

...include studying other components downstream of RTCA for their potential roles in axon regeneration. TARGET/MARKER/PATHWAY: RNA 3'-terminal phosphate cyclase (RTCA)...
BioCentury | Dec 20, 2010
Company News

Roche sales and marketing update

...Roche launched its xCELLigence System RTCA HT Instrument worldwide for high throughput analysis for research use...
BioCentury | Oct 4, 2010
Company News

Roche sales and marketing update

...Roche launched its xCELLigence RTCA Cardio Instrument outside the U.S. to monitor cardiac beating and cellular...
BioCentury | Oct 4, 2010
Company News

Acea Biosciences, Cellular Dynamics, Roche deal

...The companies combined CDI's iCell Cardiomyocytes with ACEA's and Roche's xCELLigence RTCA System to develop a...
...electrophysiological and biochemical properties of normal human heart cells. ACEA and Roche developed the xCELLigence RTCA...
...System, which monitors cell behavior in real time, under a 2007 deal. Roche markets the RTCA...
Items per page:
1 - 4 of 4